Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
9420087
Reference Type
Journal Article
Title
Development and performance evaluation of a moderate positive reference material containing genapol x-080 for hemolysis testing
Author(s)
Nomura, Y; Shindo, T; Motohashi, H; Yamakage, K; Watanabe, M; Fukui, C; Morishita, Y; Haishima, Y
Year
2019
Is Peer Reviewed?
0
Journal
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyūjo Hōkoku / Bulletin of the National Institute of Health Sciences
ISSN:
1343-4292
Publisher
National Institute of Health Sciences
Volume
2019
Issue
137
Page Numbers
32-39
Language
English
URL
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079546643&partnerID=40&md5=8f35f1c8e214e9c3310b4d1ca59f22b8
Exit
Abstract
In the previously study, we developed plasticized polyvinyl chloride (PVC) pellets namedâY-2âor âY-4âthat show weak or strong hemolytic activity depending on the content of Genapol X-080, which is used in biological safety evaluations of medical devices. However, the hemolytic activity of Y-2 was weak and inferior in reproducibility tests. This study deals with the development and performance evaluation of a moderate positive reference material (Y-3) for hemolysis testing. Y-3 was prepared as PVC pellets consisting of 33.4% di (2-ethylhexyl)-phthalate (DEHP), 4.86% epoxidized soybean oil (ESBO), 3.04 à 10â2% calcium and zinc stearates, and 0.91% Genapol X-080 as the hemolytic substance. Y-3 showed a hemolysis ratio around 40â60% with human and rabbit blood samples in American Society for Testing and Materials (ASTM) direct contact assays under the test sample/ extraction vehicle ratio specified by ISO 10993-12 (0.2 g/mL). Y-3 also exhibited hemolytic activity in extract-based assays, but the hemolysis ratio varied greatly depending on the test conditions; this likely occurred because the solubility of Genapol X-080 decreases markedly at temperatures higher than the cloud point (74â76â). As a result of optimizing the test sample/extraction vehicle ratio for each extraction condition used in the extract-based assays, a hemolysis ratio around 20â80% was yielded with human and rabbit blood when Y-3 extracts with phosphate-buffered saline were prepared under the following conditions: 0.08 g/mL at 37 or 50â for 72 h, 0.24 g/mL at 70â for 24 h, and 0.8 g/ mL at 121â for 1 h. Y-3 may be useful as a positive reference material for hemolysis testing and may show advantages over PVC sheets spiked with 0.61% (Y-2: weak positive reference material) or 5.8% (Y-4: strong positive reference material) of Genapol X-080 that induce weak or complete hemolysis, respectively, as previously reported. Hatano Research Institute is planning to start distributing Y-3 as a first positive reference material for hemolysis test on a worldwide scale beginning in the spring of 2019. © 2019, National Institute of Health Sciences. All rights reserved.
Keywords
Biological safety evaluation; Guidance; Hemolysis test; Positive reference material
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity